A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important

Pigment Cell and Melanoma Research

Volumn 26, Issue 1, 2013, Pages 128-135

  Liu, Feng ^a,b   Bessonova, Leona ^a,c   Taylor, Thomas H ^a,b,c   Ziogas, Argyrios ^a,b,c   Meyskens, Frank L ^a,b,c   Anton Culver, Hoda ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Disparity; Epidemiology; Gender; Hormones; Melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CHILD; FEMALE; HUMAN; INFANT; LIGHT EXPOSURE; MAJOR CLINICAL STUDY; MALE; MELANOMA; NON MELANOMA SKIN CANCER; ONSET AGE; PRESCHOOL CHILD; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SOLAR RADIATION; ULTRAVIOLET RADIATION; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; FEMALE; GEOGRAPHY; HUMANS; INFANT; INFANT, NEWBORN; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SEER PROGRAM; SEX CHARACTERISTICS; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UNITED STATES; YOUNG ADULT;

EID: 84871462474     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12035     Document Type: Article

References (49)

1. Ahmad, N., and Kumar, R. (2011). Steroid hormone receptors in cancer development: a target for cancer therapeutics. Cancer Lett. 300, 1-9.
2. Al-Gubory, K.H., Fowler, P.A., and Garrel, C. (2010). The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell Biol. 42, 1634-1650.
3. Bradford, P.T., Anderson, W.F., Purdue, M.P., Goldstein, A.M., and Tucker, M.A. (2010). Rising melanoma incidence rates of the trunk among younger women in the United States. Cancer Epidemiol. Biomarkers Prev. 19, 2401-2406.
4. Caini, S., Gandini, S., Sera, F., Raimondi, S., Fargnoli, M.C., Boniol, M., and Armstrong, B.K. (2009). Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant. Eur. J. Cancer 45, 3054-3063.
5. Coelho, S.G., and Hearing, V.J. (2009). UVA tanning is involved in the increased incidence of skin cancers in fair-skinned young women. Pigment Cell Melanoma Res. 23, 57-63.
6. Cordera, F., and Jordan, V.C. (2006). Steroid receptors and their role in the biology and control of breast cancer growth. Semin. Oncol. 33, 631-641.
7. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135-2147.
8. Dao Jr, H., and Kazin, R.A. (2007). Gender differences in skin: a review of the literature. Gend. Med. 4, 308-328.
9. Dennis, L.K., Lynch, C.F., Sandler, D.P., and Alavanja, M.C. (2010). Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environ. Health Perspect. 118, 812-817.
10. Driscoll, M.S., and Grant-Kels, J.M. (2007). Hormones, nevi, and melanoma: an approach to the patient. J. Am. Acad. Dermatol. 57, 919-931. quiz 932-6.
11. Fears, T.R., and Tucker, M.A. (2005). Re: sun exposure and mortality from melanoma. J. Natl Cancer Inst. 97, 1789-1790. author reply 1791.
12. Fuller, B.B., and Meyskens Jr, F.L. (1981). Endocrine responsiveness in human melanocytes and melanoma cells in culture. J. Natl Cancer Inst. 66, 799-802.
13. Gallagher, R.P., Elwood, J.M., Rootman, J., Spinelli, J.J., Hill, G.B., Threlfall, W.J., and Birdsell, J.M. (1985). Risk factors for ocular melanoma: Western Canada Melanoma Study. J. Natl Cancer Inst. 74, 775-778.
14. Garcia, A.M., Mclaren, C.E., and Meyskens Jr, F.L. (2010). Melanoma: is hair the root of the problem? Pigment Cell Melanoma Res. 24, 110-118.
15. Garibyan, L., and Fisher, D.E. (2010). How sunlight causes melanoma. Curr. Oncol. Rep. 12, 319-326.
16. Godar, D.E., Urbach, F., Gasparro, F.P., and Van Der Leun, J.C. (2003). UV doses of young adults. Photochem. Photobiol. 77, 453-457.
17. Gupta, A., and Driscoll, M.S. (2010). Do hormones influence melanoma? Facts and controversies. Clin. Dermatol. 28, 287-292.
18. Hausauer, A.K., Swetter, S.M., Cockburn, M.G., and Clarke, C.A. (2011). Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch. Dermatol. 147, 783-789.
19. Haynes, R., Pearce, J., and Barnett, R. (2008). Cancer survival in New Zealand: ethnic, social and geographical inequalities. Soc. Sci. Med. 67, 928-937.
20. Howlader, N., Noone, A., Krapcho, M. et al. (2010). SEER Cancer Statistics Review, 1975-2008. (National Cancer Institute, Bethesda, MD).
21. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., and Thun, M.J. (2009). Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249.
22. Kaae, J., Andersen, A., Boyd, H.A., Wohlfahrt, J., and Melbye, M. (2007). Reproductive history and cutaneous malignant melanoma: a comparison between women and men. Am. J. Epidemiol. 165, 1265-1270.
23. Karagas, M.R., Zens, M.S., Stukel, T.A. et al. (2006). Pregnancy history and incidence of melanoma in women: a pooled analysis. Cancer Causes Control 17, 11-19.
24. Kassi, E., and Moutsatsou, P. (2011). Glucocorticoid receptor signaling and prostate cancer. Cancer Lett. 302, 1-10.
25. Kaufman, J.M., and Vermeulen, A. (2005). The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr. Rev. 26, 833-876.
26. Lambe, M., Thorn, M., Sparen, P., Bergstrom, R., and Adami, H.O. (1996). Malignant melanoma: reduced risk associated with early childbearing and multiparity. Melanoma Res. 6, 147-153.
27. Lee, J.A. (1997). Declining effect of latitude on melanoma mortality rates in the United States. A preliminary study. Am J. Epidemiol. 146, 413-417.
28. Lee, J.A., and Storer, B.E. (1980). Excess of malignant melanomas in women in the British Isles. Lancet 2, 1337-1339.
29. Leiter, U., and Garbe, C. (2008). Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv. Exp. Med. Biol. 624, 89-103.
30. Lens, M., and Bataille, V. (2008). Melanoma in relation to reproductive and hormonal factors in women: current review on controversial issues. Cancer Causes Control 19, 437-442.
31. Liu, F., Gomez Garcia, A.M., and Meyskens Jr, F.L. (2012). NADPH oxidase 1 overexpression enhances invasion via matrix metalloproteinase-2 and epithelial-mesenchymal transition in melanoma cells. J. Invest. Dermatol. 132, 2033-2044.
32. Loke, Y.W., and King, A. (2000). Immunology of implantation. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14, 827-837.
33. Markovic, S.N., Erickson, L.A., Rao, R.D. et al. (2007). Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin. Proc. 82, 364-380.
34. Meyskens Jr, F.L., and Salmon, S.E. (1981). Inhibition of human tumor colony formation by retinoids. Ann. N. Y. Acad. Sci. 359, 414.
35. Meyskens, F.L., and Yang, S. (2011). Thinking about the role (largely ignored) of heavy metals in cancer prevention: hexavalent chromium and melanoma as a case in point. Recent Results Cancer Res. 188, 65-74.
36. Nichols, H.B., Trentham-Dietz, A., Hampton, J.M., Titus-Ernstoff, L., Egan, K.M., Willett, W.C., and Newcomb, P.A. (2006). From menarche to menopause: trends among US Women born from 1912 to 1969. Am. J. Epidemiol. 164, 1003-1011.
37. Noonan, F.P., Dudek, J., Merlino, G., and De Fabo, E.C. (2003). Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res. 16, 16-25.
38. Osterlind, A., Tucker, M.A., Stone, B.J., and Jensen, O.M. (1988). The Danish case-control study of cutaneous malignant melanoma. III. Hormonal and reproductive factors in women. Int. J. Cancer 42, 821-824.
39. Perry, J.K., Emerald, B.S., Mertani, H.C., and Lobie, P.E. (2006). The oncogenic potential of growth hormone. Growth Horm. IGF Res. 16, 277-289.
40. Purdue, M.P., Freeman, L.E., Anderson, W.F., and Tucker, M.A. (2008). Recent trends in incidence of cutaneous melanoma among US Caucasian young adults. J. Invest. Dermatol. 128, 2905-2908.
41. Red-Horse, K., Drake, P.M., and Fisher, S.J. (2004). Human pregnancy: the role of chemokine networks at the fetal-maternal interface. Expert Rev. Mol. Med. 6, 1-14.
42. Rogers, H.W., Weinstock, M.A., Harris, A.R., Hinckley, M.R., Feldman, S.R., Fleischer, A.B., and Coldiron, B.M. (2010). Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 146, 283-287.
43. Sahai, H., and Kurshid, A. (Eds.) (1996). Statistics in Epidemiology: Methods Techniques and Applications. (CRC Press: 2000 NW Corporate Blvd, Boca Raton, Florida).
44. Slominski, A. (2009). Neuroendocrine activity of the melanocyte. Exp. Dermatol. 18, 760-763.
45. Slominski, A., and Wortsman, J. (2000). Neuroendocrinology of the skin. Endocr. Rev. 21, 457-487.
46. Slominski, A., Tobin, D.J., Shibahara, S., and Wortsman, J. (2004). Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 84, 1155-1228.
47. Tadokoro, T., Yamaguchi, Y., Batzer, J., Coelho, S.G., Zmudzka, B.Z., Miller, S.A., Wolber, R., Beer, J.Z., and Hearing, V.J. (2005). Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. J. Invest. Dermatol. 124, 1326-1332.
48. Ullrich, S.E. (2007). Sunlight and skin cancer: lessons from the immune system. Mol. Carcinog. 46, 629-633.
49. Ventura, S.J., Abma, J.C., Mosher, W.D., and Henshaw, S. (2003). Revised pregnancy rates, 1990-97, and new rates for 1998-99: United States. Natl. Vital Stat. Rep. 52, 1-14.